pdufa.bio
CalendarConferencesAdCommDecisionsReadoutsResearchAccount
Home › PDUFA Calendar › MNKD

MNKD FDA calendar & decision history

MannKind Corporation · 1 upcoming · 1 past FDA decision

Upcoming FDA catalysts

MNKD · Jul 26, 2026FUROSCIX ReadyFlow Autoinjector (SCP-111) — Edema in adult patients with chronic heart failure (CHF) or chronic kidney disease (CKD)

FDA decision history (1)

May 29, 2026✓ ApprovedAfrezza (Technosphere Insulin)
Full PDUFA calendar →All FDA decisions →Phase readouts →
See the full 2026 PDUFA calendar →

This page aggregates MNKD's FDA catalysts from pdufa.bio's own calendar and decision archive. Each item links to its source page. Facts and dates only; verify against primary FDA / SEC / company filings.